360 related articles for article (PubMed ID: 12368671)
41. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
42. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
[TBL] [Abstract][Full Text] [Related]
43. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
Guthery SL; Heubi JE; Bucuvalas JC; Gross TG; Ryckman FC; Alonso MH; Balistreri WF; Hornung RW
Transplantation; 2003 Apr; 75(7):987-93. PubMed ID: 12698085
[TBL] [Abstract][Full Text] [Related]
44. A Scheduled Program of Molecular Screening for Epstein-Barr Virus Decreases the Incidence of Post-transplantation Lymphoproliferative Disease in Pediatric Liver Transplantation.
Soriano-López DP; Alcántar-Fierros JM; Hernández-Plata JA; González-Jorge AL; Velázquez-Ramos S; Flores-Hernández MA; Fuentes V; Castañeda P; Nieto J; Sánchez JL; López B; Valencia-Mayoral P; Varela-Fascinetto G
Transplant Proc; 2016 Mar; 48(2):654-7. PubMed ID: 27110023
[TBL] [Abstract][Full Text] [Related]
45. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy.
Darenkov IA; Marcarelli MA; Basadonna GP; Friedman AL; Lorber KM; Howe JG; Crouch J; Bia MJ; Kliger AS; Lorber MI
Transplantation; 1997 Sep; 64(6):848-52. PubMed ID: 9326409
[TBL] [Abstract][Full Text] [Related]
46. Pediatric liver transplantation. A single center experience spanning 20 years.
Jain A; Mazariegos G; Kashyap R; Kosmach-Park B; Starzl TE; Fung J; Reyes J
Transplantation; 2002 Mar; 73(6):941-7. PubMed ID: 11923697
[TBL] [Abstract][Full Text] [Related]
47. [Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation].
Deng Z; Jiang L; Zhou T; Shen C; Chen Q; Xia Q
Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):579-82. PubMed ID: 25224233
[TBL] [Abstract][Full Text] [Related]
48. Epstein-Barr virus serology and posttransplant lymphoproliferative disease in lung transplantation.
Wigle DA; Chaparro C; Humar A; Hutcheon MA; Chan CK; Keshavjee S
Transplantation; 2001 Dec; 72(11):1783-6. PubMed ID: 11740388
[TBL] [Abstract][Full Text] [Related]
49. Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: Analysis of ISHLT Registry.
Zaffiri L; Long A; Neely ML; Cherikh WS; Chambers DC; Snyder LD
J Heart Lung Transplant; 2020 Oct; 39(10):1089-1099. PubMed ID: 32654913
[TBL] [Abstract][Full Text] [Related]
50. Influence of Posttransplant Lymphoproliferative Disorder on Survival in Children After Heart Transplantation.
Hayes D; Breuer CK; Horwitz EM; Yates AR; Tobias JD; Shinoka T
Pediatr Cardiol; 2015 Dec; 36(8):1748-53. PubMed ID: 26187515
[TBL] [Abstract][Full Text] [Related]
51. Post-transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants.
Tajima T; Hata K; Haga H; Nishikori M; Umeda K; Kusakabe J; Miyauchi H; Okamoto T; Ogawa E; Sonoda M; Hiramatsu H; Fujimoto M; Okajima H; Takita J; Takaori-Kondo A; Uemoto S
Liver Transpl; 2021 Aug; 27(8):1165-1180. PubMed ID: 33655645
[TBL] [Abstract][Full Text] [Related]
52. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C.
McLaughlin K; Wajstaub S; Marotta P; Adams P; Grant DR; Wall WJ; Jevnikar AM; Rizkalla KS
Liver Transpl; 2000 Sep; 6(5):570-4. PubMed ID: 10980055
[TBL] [Abstract][Full Text] [Related]
53. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.
Kim JM; Lee SK; Kim SJ; Joh JW; Kwon CH; Choe YH; Shin M; Kim EY; Moon JI; Jung GO; Choi GS
Transplant Proc; 2010 Apr; 42(3):895-9. PubMed ID: 20430199
[TBL] [Abstract][Full Text] [Related]
54. Managing the challenge of PTLD in liver and bowel transplant recipients.
Lauro A; Arpinati M; Pinna AD
Br J Haematol; 2015 Apr; 169(2):157-72. PubMed ID: 25377273
[TBL] [Abstract][Full Text] [Related]
55. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience.
Peters AC; Akinwumi MS; Cervera C; Mabilangan C; Ghosh S; Lai R; Iafolla M; Doucette K; Preiksaitis JK
Transplantation; 2018 Sep; 102(9):1553-1562. PubMed ID: 29485513
[TBL] [Abstract][Full Text] [Related]
56. Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival.
Kremers WK; Devarbhavi HC; Wiesner RH; Krom RA; Macon WR; Habermann TM
Am J Transplant; 2006 May; 6(5 Pt 1):1017-24. PubMed ID: 16611339
[TBL] [Abstract][Full Text] [Related]
57. Early- and late-onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipients.
Abdulovski R; Møller DL; Knudsen AD; Sørensen SS; Rasmussen A; Nielsen SD; Wareham NE
Eur J Haematol; 2022 Oct; 109(4):343-350. PubMed ID: 35719018
[TBL] [Abstract][Full Text] [Related]
58. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
[TBL] [Abstract][Full Text] [Related]
59. Post-transplant lymphoproliferative disease in liver transplantation.
Dhillon MS; Rai JK; Gunson BK; Olliff S; Olliff J
Br J Radiol; 2007 May; 80(953):337-46. PubMed ID: 17392399
[TBL] [Abstract][Full Text] [Related]
60. Development of lymphoproliferative disease after liver transplantation.
Marqués E; Jiménez C; Manrique A; Vallejo GH; Clemares M; Ortega P; Moreno E
Transplant Proc; 2008 Nov; 40(9):2988-9. PubMed ID: 19010169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
